Why Are Indaptus Therapeutics Shares Shooting Higher On Wednesday?
Assembly Bio Stock Tumbles On Discontinuation Of Hepatitis B Trial
Vir Biotechnology Starts Dosing In Mid-Stage Hepatitis B Trial With Combination Therapy
Enochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program
Hepatitis B Recent News
Arbutus Biopharma Stock Jumps On Encouraging Data From Hepatitis B Candidate
IPO Outlook: Solar Power Company Array Technologies, Chinese Retailer Miniso Lead Possible 9 IPO Week
Analyst Downgrades Arbutus Biopharma On Valuation After 80% Run
Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson
Dynavax Clears Heplisav-B Hurdle With CDC Recommendation
Dynavax Gets 12-1 FDA Vote For Hepatitis B Vaccine
Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger
Exclusive: Dicerna CEO Talks Goals For 2017, Competitors And Prospects Under Trump
Exclusive: Dicerna CEO Discusses Financials And Institutional Investors
Exclusive: Dicerna CEO Talks Products, Partnerships And Stock Performance
Exclusive: Dicerna CEO Explains RNA Interference And How It's Used To Treat Rare Genetic Diseases
Arbutus Biopharma Taken Off Of Chardan's Sell List
Gilead's 'R&D Day' Points To Upside For Shareholders